Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNMT | P11086 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6518706 | 0.84 | — | — | |
| SCHEMBL15980346 | 0.80 | PNMT (0.37) | PNMT | |
| SCHEMBL22503335 | 0.78 | PNMT (0.32) | PNMT | |
| SCHEMBL17339848 | 0.76 | PNMT (0.36) | PNMT | |
| SCHEMBL13183593 | 0.65 | PNMT (0.48) | PNMT | |
| SCHEMBL19122298 | 0.65 | — | — | |
| SCHEMBL24960502 | 0.65 | ALDH1A1 (0.30) | — | |
| SCHEMBL22601014 | 0.65 | ALDH1A1 (0.30) | — | |
| SCHEMBL15274297 | 0.64 | — | — | |
| SCHEMBL2917929 | 0.64 | PNMT (0.34) | PNMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1082363-A1 | ORGANOMETAL COMPOUND, CATALYST SYSTEM CONTAINING SAID ORGANOMETAL COMPOUND AND ITS USE | Basell Polyolefine GmbH (DE) | 2001-03-14 | — | — | EP | claimed |
| WO-2000044799-A1 | ORGANOMETAL COMPOUND, CATALYST SYSTEM CONTAINING SAID ORGANOMETAL COMPOUND AND ITS USE | TARGOR GMBH (DE) | 2000-08-03 | — | — | WO | claimed |
| EP-3024040-B1 | ORGANIC FILM TRANSISTOR, ORGANIC SEMICONDUCTOR FILM, AND ORGANIC SEMICONDUCTOR MATERIAL AND USE APPLICATIONS THEREOF | FUJIFILM CORP (JP) | 2019-05-08 | — | — | EP | disclosed |
| US-9511056-B2 | Antiviral compounds | GILEAD PHARMASSET LLC (US) | 2016-12-06 | — | — | US | disclosed |
| US-9120779-B2 | Inhibitors of HCV NS5A | PRESIDIO PHARMACEUTICALS, INC. (US) | 2015-09-01 | — | — | US | disclosed |
| US-20150232455-A1 | ANTI-VIRAL COMPOUNDS | ABBVIE INC. | 2015-08-20 | — | — | US | disclosed |
| US-20150158909-A1 | ANTI-VIRAL COMPOUNDS | ABBVIE INC. | 2015-06-11 | — | — | US | disclosed |
| US-20150057218-A1 | INHIBITORS OF HCV NS5A | PRESIDIO PHARMACEUTICALS INC (US) | 2015-02-26 | — | — | US | disclosed |
| US-20150038501-A1 | INHIBITORS OF HCV NS5A | PRESIDIO PHARMACEUTICALS, INC. | 2015-02-05 | — | — | US | disclosed |
| US-8921369-B2 | Inhibitors of HCV NS5A | PRESIDIO PHARMACEUTICALS, INC. (US) | 2014-12-30 | — | — | US | disclosed |
| US-8877707-B2 | Inhibitors of HCV NS5A | PRESIDIO PHARMACEUTICALS, INC. (US) | 2014-11-04 | — | — | US | disclosed |
| WO-2001048035-A2 | CHEMICAL COMPOUND, METHOD FOR THE PRODUCTION THEREOF AND ITS USE IN CATALYST SYSTEMS FOR PRODUCING POLYOLEFINS | BASELL POLYOLEFINE GMBH (DE) | 2001-07-05 | — | — | WO | disclosed |
| EP-1082363-A1 | ORGANOMETAL COMPOUND, CATALYST SYSTEM CONTAINING SAID ORGANOMETAL COMPOUND AND ITS USE | Basell Polyolefine GmbH (DE) | 2001-03-14 | — | — | EP | disclosed |
| EP-1054914-A1 | ZWITTERIONIC, NEUTRAL TRANSITION METAL COMPOUND | Basell Polyolefine GmbH (DE) | 2000-11-29 | — | — | EP | disclosed |
| WO-2000064906-A1 | CHEMICAL COMPOUND, METHOD FOR THE PRODUCTION THEREOF, AND ITS USE IN A CATALYST SYSTEM FOR PRODUCING POLYOLEFINS | BASELL POLYOLEFINE GMBH (DE) | 2000-11-02 | — | — | WO | disclosed |
| WO-2000062928-A1 | CATALYST SYSTEM | BASELL POLYOLEFINE GMBH (DE) | 2000-10-26 | — | — | WO | disclosed |
| WO-2000020466-A9 | CATALYST SYSTEM | TARGOR GMBH (DE) | 2000-09-21 | — | — | WO | disclosed |
| WO-2000044799-A1 | ORGANOMETAL COMPOUND, CATALYST SYSTEM CONTAINING SAID ORGANOMETAL COMPOUND AND ITS USE | TARGOR GMBH (DE) | 2000-08-03 | — | — | WO | disclosed |
| WO-2000035973-A1 | ZWITTERIONIC, NEUTRAL TRANSITION METAL COMPOUND WHICH CONTAINS BORON | TARGOR GMBH (DE) | 2000-06-22 | — | — | WO | disclosed |
| WO-2000018773-A1 | CHEMICAL COMPOUND | TARGOR GMBH (DE) | 2000-04-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150232455-A1 | ANTI-VIRAL COMPOUNDS | HAVCR2, EIF2AK2, MAVS | PNMT 2207/4885 |
| US-20150057218-A1 | INHIBITORS OF HCV NS5A | HAVCR2, MAVS, EIF2AK2 | PNMT 3973/4885 |
| US-20150038501-A1 | INHIBITORS OF HCV NS5A | HAVCR2, MAVS, EIF2AK2 | PNMT 3973/4885 |
| US-20150158909-A1 | ANTI-VIRAL COMPOUNDS | HAVCR2, EIF2AK2, MAVS | PNMT 2207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.